Back to journals
Academic JournalOpen Access

Brain Research Bulletin

3 Papers Indexed in Blossom

Data updated

Research Footprint

Brain Research Bulletin has 3 tracked papers indexed in Blossom (2016–2026) from 18 authors, most often covering Ketamine, Ayahuasca and LSD, across Neuroimaging & Brain Measures, Anxiety Disorders and Depressive Disorders.

Published Papers

Open Accessindividual

Ketamine-induced changes in accumbal glutamate and their association with altered states of consciousness

This brain imaging study (n=10) in healthy participants used magnetic resonance spectroscopy to measure glutamate levels in the nucleus accumbens before and during a single intravenous ketamine infusion (50mg/70kg). Ketamine did not significantly increase overall glutamate levels, but individual changes in glutamate were positively associated with anxious ego dissolution and reduced vigilance.

Published
Journal
Brain Research Bulletin
Authors
Gubser, L. P., Trippel, A. S., Zoelch, N., Engeli, E. J. E., Herdener, M.
Open Accessmeta

Ayahuasca: pharmacology, neuroscience and therapeutic potential

This review (2016) examines the pharmacology and neuroscience of ayahuasca, and preliminary findings which indicate the psychological mechanisms associated with its therapeutic benefits are similar to those of mindfulness-based therapy. Ayahuasca appears to enhance self-acceptance and decentering, which converges on evidence from neuroimaging studies that show activation in areas associated with emotional processing and memory formation, thereby enabling individuals to review emotional events with increased vividness and a heightened sense of “reality”. This suggests potential to treat trauma-related conditions and other disorders like borderline personality disorder.

Published
Journal
Brain Research Bulletin
Authors
Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., De La Fuente Revenga, M., Friedlander, P., Feilding, A., Riba, J.
Open Accessmeta

Ketamine abuse potential and use disorder

This review (2016) contrasts the therapeutic potential of ketamine as a fast-acting antidepressant to its potential for substance abuse. It specifically examines the social harms, the psycho-physiological and neurochemical effects, reinforcement mechanisms, and the treatment of ketamine abuse. It concludes that ketamine elicits significant reinforcing and toxic effects, which must be weighed against its antidepressant potential, which needs to be investigated in greater depth.

Published
Journal
Brain Research Bulletin
Authors
Liu, Y., Lin, D., Wu, B., Zhou, W.

Quick Facts

Papers Indexed
3
h-Index
149
Open Access
Yes
Publisher
Elsevier
Country
United States
Website
Visit